3//SEC Filing
Biotest Divestiture Trust 3
Accession 0001123292-18-000891
CIK 0001368514other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:32 PM ET
Size
5.4 KB
Accession
0001123292-18-000891
Insider Transaction Report
Form 3
Biotest Divestiture Trust
10% Owner
Holdings
- 8,591,160(indirect: By Biotest Pharmaceuticals Corporation)
Non-Voting Common Stock
- 10,109,534(indirect: By Biotest Pharmaceuticals Corporation)
Common Stock
Footnotes (1)
- [F1]Represents securities owned by Biotest Pharmaceuticals Corporation ("BPC"). BPC is a wholly-owned subsidiary of Biotest US Corporation ("Biotest US"), which is wholly-owned by The Biotest Divestiture Trust (the "Trust"). Eric Rosenbach, the trustee of the Trust, is the sole director of each of BPC and Biotest US and has voting and investment discretion with respect to the securities of the issuer held by BPC. Mr. Rosenbach has no pecuniary interest in such securities.
Documents
Issuer
ADMA BIOLOGICS, INC.
CIK 0001368514
Entity typeother
IncorporatedMD
Related Parties
1- filerCIK 0001748876
Filing Metadata
- Form type
- 3
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 4:32 PM ET
- Size
- 5.4 KB